Top

Published in:

Open Access 01-06-2011

Salvage Cryotherapy for Radiation-Recurrent Prostate Cancer: Outcomes and Complications

Authors: David S. Finley, Arie S. Belldegrun

Published in: Current Urology Reports | Issue 3/2011

Abstract

Potentially curative salvage options for radio-recurrent prostate cancer include prostatectomy, brachytherapy, high-intensity focused ultrasound, and cryotherapy. Salvage cryoablation technology, surgical technique, oncologic outcomes, and complication rates have improved dramatically over the past few decades, shifting this treatment modality from investigational status to an established therapeutic option. In this review, we focus on the most up-to-date oncologic and functional outcomes, as well as complications of salvage cryotherapy for radiation-recurrent prostate cancer.

Mettlin CJ, Murphy GP, Rosenthal DS, et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1679–84.PubMedCrossRef

Mettlin CJ, Murphy GP, McDonald CJ, et al. The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer. 1999;86:1877–82.PubMedCrossRef

Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598–604.PubMedCrossRef

D’Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J Clin Oncol. 2008;26:2979–83.PubMedCrossRef

Suzuki N, Shimbo M, Amiya Y, et al. Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absence of lymph node invasion. Jpn J Clin Oncol. 2010;40:652–7.PubMedCrossRef

Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005;173:373–9.PubMedCrossRef

Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of radiology 95–09. J Clin Oncol. 2010;28:1106–11.PubMedCrossRef

Crook JM, Perry GA, Robertson S, Esche BA. Routine biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology. 1995;45:624–31.PubMedCrossRef

Siddiqui SA, Mynderse LA, Zincke H, et al. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007;70:80–5.PubMedCrossRef

10.

Chin JL, Lim D, Abdelhady M. Review of primary and salvage cryoablation for prostate cancer. Cancer Control. 2007;14:231–7.PubMed

11.

Finley DS, Pouliot F, Miller DR, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010;37:67–82.PubMedCrossRef

12.

• Babaian RJ, Donnelly B, Bahn D, et al.: AUA Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008. 180:1993–2004. This is the American Urological Association consensus statement on the cryosurgery, an evidence-based review of the literature with panel recommendations. PubMedCrossRef

13.

Nguyen PL, D'Amico AV, Lee AK, Suh WW. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007;110:1417–28.PubMedCrossRef

14.

Spiess PE, Lee AK, Leibovici D, et al. Presalvage prostate-specific antigen and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006;107:275–80.PubMedCrossRef

15.

Vergunst H, Langenhuijsen JF. Rebuttal from Authors re: J. Stephen Jones. Ten Misconceptions regarding cryotherapy for prostate cancer. Eur Urol. 2009;55:52–5.CrossRef

16.

• Williams A, Martinez C., Chalasani V, Pautler SE, Chin JL. Long term results of salvage cryotherapy for prostate cancer. Presented at the 11th Annual Meeting of the Society of Urologic Oncology, Bethesda, Maryland; Dec 8–10, 2010. This is one of the largest salvage cryoablation series and longest series to date

17.

Chin JL, Pautler SE, Mouraviev V, et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001;165:1937–42.PubMedCrossRef

18.

De la Taille A, Benson MC, Bagiella E, et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int. 2000;85:281–6.CrossRef

19.

Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002;20:2664–71.PubMedCrossRef

20.

Pisters LL, Perrotte P, Scott SM, et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999;17:2514–20.PubMed

21.

Spiess PE, Katz AE, Chin JL, et al. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2009;106:194–8.PubMedCrossRef

22.

Bahn DK, Lee F, Silverman P, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2:111–4.PubMed

23.

Cheetham P, Truesdale M, Chaudhury S, et al. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endo. 2010;24:1123–9.

24.

Huang WC, Kuroiwa K, Serio AM, et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol. 2007;177:1324–9.PubMedCrossRef

25.

Klossner DP, Baust JM, VanBuskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int. 2008;101:1310–6.PubMedCrossRef

26.

• Rastinehad A, Benjamin C, Chung P, et al.: Cancer detection rates on MR/Ultrasound fused image guided prostate biopsies directly correlates with multi-parametric MRI. Presented at the 11th Annual Meeting of the Society of Urologic Oncology, Bethesda, Maryland; Dec 8–10, 2010. This article provides one of several examples of rapidly improving biopsy technique using fusion of magnetic resonance and ultrasound.

27.

Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008;72:1315–8.PubMedCrossRef

28.

• Abdelhady M, Abusamra A, Elmaadawi A, et al.: Health related quality of life (HRQOL) outcome after salvage cryosurgery of the prostate: comparison with outcome after primary radiotherapy. J Urol suppl 2007. 177:3. This is one of few HRQOL studies on salvage cryoablation using validated instruments.

29.

Robinson JW, Donnelly BJ, Coupland K, et al. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urol Oncol. 2006;24:472–86.PubMedCrossRef

30.

Perrotte P, Litwin M, McGuire EJ, et al. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol. 1999;162:398–402.PubMedCrossRef

31.

Levy DA. Correlation of thermocouple data with voiding function after prostate cryoablation. Urology. 2010;75:482–7.PubMedCrossRef

32.

De la Taille A, Hayek O, Benson MC, et al. Salvage cryotherapy for recurrent prostate cancer after radiation treatment: the Columbia experience. Urology. 2000;55:79–84.PubMedCrossRef

33.

Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol. 1998;159:477–84.PubMedCrossRef

34.

Yin L, Choi WW, Gu X, et al.: Complications of primary vs salvage cryotherapy for prostate cancer. Presented at the American Urologic Association Meeting. San Francisco, California; May 29-June 3, 2010, Abstract #1066.

35.

Anastasiadis AG, Sachdev R, Salomon L, et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003;129:676–82.PubMedCrossRef

36.

Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100:760–4.PubMedCrossRef

37.

Pisters LL, Rewcastle JC, Donnelly BJ, et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180:559–64.PubMedCrossRef

38.

Donnelly BJ, Saliken JC, Ernst DS, et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis. 2005;8:235–42.PubMedCrossRef

39.

Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJUI. 2004;93:14–8.CrossRef

40.

Ng CK, Moussa M, Downey DB, Chin JL. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007;178:1253–7.PubMedCrossRef

Title: Salvage Cryotherapy for Radiation-Recurrent Prostate Cancer: Outcomes and Complications
Authors: David S. Finley
Arie S. Belldegrun
Publication date: 01-06-2011
Publisher: Current Science Inc.
Published in: Current Urology Reports / Issue 3/2011
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-011-0182-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Salvage Cryotherapy for Radiation-Recurrent Prostate Cancer: Outcomes and Complications

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Use of Testosterone Replacement Therapy in Patients with Prostate Cancer

Current Clinical Trials in Castrate-Resistant Prostate Cancer

Quality of Evidence to Compare Outcomes of Open and Robot-Assisted Laparoscopic Prostatectomy

Androgen Suppression Strategies for Prostate Cancer: Is There an Ideal Approach?

Complications of Pelvic Lymph Node Dissection for Prostate Cancer

Management of Rising Prostate-specific Antigen After a Negative Biopsy